| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.59e-16 | 14 | 178 | 9 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 2.13e-13 | 23 | 178 | 9 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 2.49e-12 | 29 | 178 | 9 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 2.49e-12 | 29 | 178 | 9 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.26e-11 | 34 | 178 | 9 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 4.39e-10 | 49 | 178 | 9 | GO:0051861 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 CEACAM3 SIRPA PITPNM1 PSG8 | 8.43e-10 | 149 | 178 | 13 | GO:1990782 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.18e-08 | 70 | 178 | 9 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.73e-08 | 73 | 178 | 9 | GO:0170055 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 SLC7A11 SLC25A38 SLC47A1 PSG8 | 4.51e-08 | 207 | 178 | 13 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 SLC7A11 SLC25A38 SLC47A1 PSG8 | 4.78e-08 | 208 | 178 | 13 | GO:0005342 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.10e-07 | 90 | 178 | 9 | GO:0008028 | |
| GeneOntologyMolecularFunction | lipid transporter activity | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 STARD5 PITPNM1 PSG8 | 1.54e-06 | 196 | 178 | 11 | GO:0005319 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 SLC7A11 SLC25A38 SLC47A1 PSG8 | 2.39e-06 | 293 | 178 | 13 | GO:0008514 |
| GeneOntologyMolecularFunction | growth factor receptor binding | 3.57e-06 | 173 | 178 | 10 | GO:0070851 | |
| GeneOntologyMolecularFunction | transporter activity | ATP5PO PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 SLC5A7 PKD1L2 AQP4 SLC7A11 RYR3 STARD5 TFRC SLC5A5 PITPNM1 KCNK18 SIDT2 SLC8B1 CLCN2 P2RX2 SLC18A3 SLC25A38 LRP2 SLC47A1 PSG8 | 3.64e-06 | 1289 | 178 | 29 | GO:0005215 |
| GeneOntologyMolecularFunction | calmodulin binding | 7.18e-06 | 230 | 178 | 11 | GO:0005516 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP5PO PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 SLC5A7 PKD1L2 AQP4 SLC7A11 RYR3 TFRC SLC5A5 KCNK18 SIDT2 SLC8B1 CLCN2 P2RX2 SLC18A3 SLC25A38 SLC47A1 PSG8 | 1.78e-05 | 1180 | 178 | 26 | GO:0022857 |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.96e-05 | 210 | 178 | 10 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatase binding | 2.60e-05 | 264 | 178 | 11 | GO:0019902 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.31e-04 | 316 | 178 | 11 | GO:0035091 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 1.63e-04 | 324 | 178 | 11 | GO:0005126 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 TENM4 SUPT5H AOC3 PSG8 | 2.47e-04 | 398 | 178 | 12 | GO:0046982 |
| GeneOntologyMolecularFunction | aliphatic amine oxidase activity | 4.69e-04 | 4 | 178 | 2 | GO:0052595 | |
| GeneOntologyMolecularFunction | protein kinase binding | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 CEACAM3 DACT2 XIAP NBEA SIRPA TFRC PITPNM1 PSG8 MAPK1 | 8.27e-04 | 873 | 178 | 18 | GO:0019901 |
| GeneOntologyMolecularFunction | histone H3K9me2/H3K9me3 demethylase activity | 1.16e-03 | 6 | 178 | 2 | GO:0140684 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.61e-03 | 7 | 178 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.91e-03 | 310 | 178 | 9 | GO:0030246 | |
| GeneOntologyMolecularFunction | mercury ion binding | 2.14e-03 | 8 | 178 | 2 | GO:0045340 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 2.92e-17 | 17 | 176 | 10 | GO:0070342 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 3.77e-16 | 14 | 176 | 9 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 9.35e-16 | 15 | 176 | 9 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 9.35e-16 | 15 | 176 | 9 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 9.35e-16 | 15 | 176 | 9 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 9.35e-16 | 15 | 176 | 9 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 2.12e-15 | 16 | 176 | 9 | GO:0038016 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 4.47e-15 | 17 | 176 | 9 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 4.47e-15 | 17 | 176 | 9 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 8.88e-15 | 18 | 176 | 9 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.02e-14 | 20 | 176 | 9 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 5.25e-14 | 21 | 176 | 9 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 5.25e-14 | 21 | 176 | 9 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 5.25e-14 | 21 | 176 | 9 | GO:0002838 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 8.68e-14 | 32 | 176 | 10 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 8.83e-14 | 22 | 176 | 9 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.44e-13 | 23 | 176 | 9 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.44e-13 | 23 | 176 | 9 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 2.29e-13 | 24 | 176 | 9 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 2.29e-13 | 24 | 176 | 9 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 2.29e-13 | 24 | 176 | 9 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 3.55e-13 | 25 | 176 | 9 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 3.55e-13 | 25 | 176 | 9 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 8.02e-13 | 27 | 176 | 9 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.17e-12 | 28 | 176 | 9 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.69e-12 | 29 | 176 | 9 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 3.35e-12 | 31 | 176 | 9 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 4.63e-12 | 32 | 176 | 9 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 4.63e-12 | 32 | 176 | 9 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 6.31e-12 | 33 | 176 | 9 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 6.31e-12 | 33 | 176 | 9 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 8.52e-12 | 34 | 176 | 9 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 8.52e-12 | 34 | 176 | 9 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.14e-11 | 35 | 176 | 9 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.78e-11 | 70 | 176 | 11 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.57e-11 | 38 | 176 | 9 | GO:2000345 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PSG1 PSG2 PCDHGB3 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PCDHB5 ITGA5 CEACAM19 TENM4 PTPRS PCDH19 PCDH15 PSG8 ADGRL3 | 2.59e-11 | 313 | 176 | 19 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 3.32e-11 | 39 | 176 | 9 | GO:0045717 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 4.01e-11 | 56 | 176 | 10 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 4.25e-11 | 40 | 176 | 9 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 5.41e-11 | 41 | 176 | 9 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 6.84e-11 | 42 | 176 | 9 | GO:0090330 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | WHRN PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LAMA2 XIAP IDUA BBS10 TFRC STRAP PCDH15 PSG8 USH2A FOXC1 | 7.92e-11 | 334 | 176 | 19 | GO:0060249 |
| GeneOntologyBiologicalProcess | tissue homeostasis | WHRN PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LAMA2 XIAP IDUA BBS10 TFRC STRAP PCDH15 PSG8 USH2A FOXC1 | 7.92e-11 | 334 | 176 | 19 | GO:0001894 |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 8.02e-11 | 80 | 176 | 11 | GO:0046850 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.21e-10 | 83 | 176 | 11 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.33e-10 | 45 | 176 | 9 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.64e-10 | 46 | 176 | 9 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.64e-10 | 46 | 176 | 9 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.01e-10 | 47 | 176 | 9 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 2.01e-10 | 47 | 176 | 9 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 2.01e-10 | 47 | 176 | 9 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 2.99e-10 | 49 | 176 | 9 | GO:0002837 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 2.99e-10 | 49 | 176 | 9 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.62e-10 | 50 | 176 | 9 | GO:0002834 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 4.66e-10 | 71 | 176 | 10 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 5.24e-10 | 52 | 176 | 9 | GO:0031342 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 5.38e-10 | 72 | 176 | 10 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 6.00e-10 | 96 | 176 | 11 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 6.27e-10 | 53 | 176 | 9 | GO:0034110 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PSG1 PSG2 PCDHGB3 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PCDHB5 PCDH19 PCDH15 PSG8 | 7.98e-10 | 187 | 176 | 14 | GO:0007156 |
| GeneOntologyBiologicalProcess | bone resorption | 8.39e-10 | 99 | 176 | 11 | GO:0045453 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.70e-09 | 59 | 176 | 9 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.99e-09 | 60 | 176 | 9 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.99e-09 | 60 | 176 | 9 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.31e-09 | 61 | 176 | 9 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 2.85e-09 | 85 | 176 | 10 | GO:1903670 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 3.59e-09 | 87 | 176 | 10 | GO:0001974 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 4.76e-09 | 66 | 176 | 9 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 5.46e-09 | 67 | 176 | 9 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 7.13e-09 | 69 | 176 | 9 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 8.13e-09 | 70 | 176 | 9 | GO:1900047 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 8.56e-09 | 95 | 176 | 10 | GO:0070527 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 9.24e-09 | 71 | 176 | 9 | GO:0043114 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.05e-08 | 72 | 176 | 9 | GO:0050819 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.11e-08 | 126 | 176 | 11 | GO:1903035 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.19e-08 | 73 | 176 | 9 | GO:0042304 | |
| GeneOntologyBiologicalProcess | bone remodeling | 1.21e-08 | 127 | 176 | 11 | GO:0046849 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 1.31e-08 | 128 | 176 | 11 | GO:0034103 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.70e-08 | 76 | 176 | 9 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-1 production | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CASP8 SIRPA AQP4 PSG8 | 1.86e-08 | 165 | 176 | 12 | GO:0032652 |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 2.27e-08 | 105 | 176 | 10 | GO:0042267 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 2.69e-08 | 80 | 176 | 9 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 2.73e-08 | 107 | 176 | 10 | GO:0042130 | |
| GeneOntologyBiologicalProcess | interleukin-1 production | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CASP8 SIRPA AQP4 PSG8 | 2.77e-08 | 171 | 176 | 12 | GO:0032612 |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 3.26e-08 | 109 | 176 | 10 | GO:0002228 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | BOC DCHS2 PSG1 PSG2 PCDHGB3 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PCDHB5 SIRPA DCC ITGA5 AQP4 SLC7A11 FCHO1 TFRC ARG1 CEACAM19 NEO1 TENM4 EFNB3 PTPRS PCDH19 PCDH15 PSG8 ADGRL3 | 3.61e-08 | 1077 | 176 | 29 | GO:0098609 |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 4.61e-08 | 85 | 176 | 9 | GO:0002762 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 5.01e-08 | 114 | 176 | 10 | GO:0045824 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 5.11e-08 | 86 | 176 | 9 | GO:0042058 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 TRB PSG9 PSG11 RNF19B ARG1 PSG8 | 7.47e-08 | 187 | 176 | 12 | GO:0001909 |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 8.40e-08 | 91 | 176 | 9 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 8.40e-08 | 91 | 176 | 9 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 1.02e-07 | 93 | 176 | 9 | GO:1901184 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 1.02e-07 | 93 | 176 | 9 | GO:1900046 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | WHRN FLNB PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 DACT2 E2F7 CLOCK SLC7A11 SIDT2 PNPLA1 CLCN2 PAX8 PTPRS PCDH15 PSG8 PAX2 USH2A PLK4 FOXC1 | 1.04e-07 | 870 | 176 | 25 | GO:0030855 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.12e-07 | 124 | 176 | 10 | GO:0001910 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 1.12e-07 | 124 | 176 | 10 | GO:0050672 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 1.12e-07 | 124 | 176 | 10 | GO:0034109 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 1.30e-07 | 126 | 176 | 10 | GO:0032945 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.20e-15 | 16 | 179 | 9 | GO:0070021 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.20e-08 | 98 | 179 | 10 | GO:0060170 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 7.88e-08 | 90 | 179 | 9 | GO:0016328 | |
| GeneOntologyCellularComponent | T cell receptor complex | 1.66e-07 | 163 | 179 | 11 | GO:0042101 | |
| GeneOntologyCellularComponent | apical plasma membrane | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 SLC5A7 SI RAB18 P2RX2 LRP2 SLC47A1 PSG8 USH2A | 2.17e-07 | 487 | 179 | 18 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 SLC5A7 SI SLC7A11 RAB18 P2RX2 LRP2 SLC47A1 PSG8 USH2A | 8.42e-07 | 592 | 179 | 19 | GO:0045177 |
| GeneOntologyCellularComponent | cell surface | BOC ATP5PO PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 CEACAM3 SIRPA DCC ITGA5 CR2 AQP4 SLC7A11 TFRC CEACAM19 NEO1 P2RX2 AOC3 LRP2 LMAN2 PSG8 DCBLD2 | 9.31e-07 | 1111 | 179 | 27 | GO:0009986 |
| GeneOntologyCellularComponent | cell projection membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 ITGA5 AQP4 SLC7A11 BBS7 LRP2 PSG8 USH2A | 1.00e-06 | 431 | 179 | 16 | GO:0031253 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.04e-06 | 157 | 179 | 10 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 2.15e-06 | 170 | 179 | 10 | GO:1902911 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 AQP4 TFRC CLCN2 SLC47A1 PSG8 | 4.07e-06 | 320 | 179 | 13 | GO:0016323 |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 TRB PSG9 PSG11 ITGA5 TFRC TRBV25-1 PSG8 | 1.07e-05 | 350 | 179 | 13 | GO:0098802 |
| GeneOntologyCellularComponent | basal plasma membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 AQP4 TFRC CLCN2 SLC47A1 PSG8 | 1.20e-05 | 354 | 179 | 13 | GO:0009925 |
| GeneOntologyCellularComponent | periciliary membrane compartment | 1.21e-05 | 6 | 179 | 3 | GO:1990075 | |
| GeneOntologyCellularComponent | basal part of cell | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 AQP4 TFRC CLCN2 SLC47A1 PSG8 | 2.40e-05 | 378 | 179 | 13 | GO:0045178 |
| GeneOntologyCellularComponent | cilium | WHRN PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 OXCT2 DNAI3 BBS10 AGBL4 BBS7 PCDH15 PSG8 SPAG17 USP48 USH2A DNAH6 KIF17 | 2.98e-05 | 898 | 179 | 21 | GO:0005929 |
| GeneOntologyCellularComponent | receptor complex | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 TRB PSG9 PSG11 ITGA5 CR2 TFRC TRBV25-1 P2RX2 LRP2 PSG8 | 4.21e-05 | 581 | 179 | 16 | GO:0043235 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 4.99e-05 | 9 | 179 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | cell-cell junction | DCHS2 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PCDHB5 CNTNAP1 ITGA5 AQP4 PSG8 ADGRL3 CDK4 | 5.15e-05 | 591 | 179 | 16 | GO:0005911 |
| GeneOntologyCellularComponent | adherens junction | 9.18e-05 | 212 | 179 | 9 | GO:0005912 | |
| GeneOntologyCellularComponent | anchoring junction | FLNB DCHS2 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 TNC PSG9 PSG11 PCDHB5 CNTNAP1 ITGA5 AQP4 SORBS3 PSG8 MAPK1 ARHGAP21 ADGRL3 CDK4 | 9.78e-05 | 976 | 179 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | somatodendritic compartment | BOC WHRN ABHD17A FLNB RBFOX3 MAOB SRD5A1 SLC5A7 LAMA2 PUM2 CRTC1 ABHD17C ARG1 NEO1 CLCN2 P2RX2 PTPRS XRN1 LRP2 MAPK1 KLHL14 USH2A KIF17 HNRNPR | 1.34e-04 | 1228 | 179 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | cell body | BOC WHRN FLNB RBFOX3 MAOB SRD5A1 SLC5A7 PUM2 CASP8 CRTC1 ARG1 PITPNM1 NEO1 CLCN2 P2RX2 PTPRS XRN1 MAPK1 KLHL14 USH2A | 1.44e-04 | 929 | 179 | 20 | GO:0044297 |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.54e-04 | 335 | 179 | 11 | GO:0061695 | |
| GeneOntologyCellularComponent | external side of plasma membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 ITGA5 CR2 AQP4 TFRC LRP2 PSG8 | 1.59e-04 | 519 | 179 | 14 | GO:0009897 |
| GeneOntologyCellularComponent | ER membrane insertion complex | 2.10e-04 | 14 | 179 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | neuronal cell body | BOC WHRN FLNB RBFOX3 MAOB SRD5A1 SLC5A7 PUM2 CRTC1 ARG1 NEO1 CLCN2 P2RX2 PTPRS XRN1 MAPK1 KLHL14 USH2A | 3.08e-04 | 835 | 179 | 18 | GO:0043025 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 4.16e-04 | 157 | 179 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | USH2 complex | 4.33e-04 | 4 | 179 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | axonal growth cone | 5.89e-04 | 45 | 179 | 4 | GO:0044295 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 6.23e-04 | 80 | 179 | 5 | GO:0005905 | |
| GeneOntologyCellularComponent | CLOCK-BMAL transcription complex | 7.17e-04 | 5 | 179 | 2 | GO:1990513 | |
| GeneOntologyCellularComponent | postsynaptic membrane | ABHD17A NBEA DCC ITGA5 CSMD2 ABHD17C NEO1 EFNB3 PTPRS USP48 ADGRL3 | 7.65e-04 | 405 | 179 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | stereocilia ankle link | 1.07e-03 | 6 | 179 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 1.07e-03 | 6 | 179 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | postsynapse | WHRN ABHD17A SYN3 LAMA2 CRTC1 NBEA DCC ITGA5 CSMD2 ABHD17C TFRC NEO1 EFNB3 P2RX2 PTPRS MAPK1 USP48 KIF17 ADGRL3 | 1.20e-03 | 1018 | 179 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | plasma membrane protein complex | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 TRB PSG9 PSG11 CASP8 ITGA5 TFRC TRBV25-1 NEO1 SLC18A3 PSG8 | 1.21e-03 | 785 | 179 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | astrocyte projection | 1.24e-03 | 25 | 179 | 3 | GO:0097449 | |
| GeneOntologyCellularComponent | synaptic membrane | ABHD17A SLC5A7 NBEA DCC ITGA5 CSMD2 ABHD17C NEO1 EFNB3 P2RX2 PTPRS USP48 ADGRL3 | 1.59e-03 | 583 | 179 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.77e-03 | 201 | 179 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.97e-03 | 8 | 179 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | inner dynein arm | 3.14e-03 | 10 | 179 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.16e-03 | 223 | 179 | 7 | GO:0098862 | |
| GeneOntologyCellularComponent | side of membrane | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 ITGA5 CR2 AQP4 GEM RYR3 TFRC LRP2 PSG8 | 3.57e-03 | 875 | 179 | 16 | GO:0098552 |
| GeneOntologyCellularComponent | basement membrane | 4.03e-03 | 122 | 179 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | distal axon | 4.39e-03 | 435 | 179 | 10 | GO:0150034 | |
| GeneOntologyCellularComponent | astrocyte end-foot | 4.55e-03 | 12 | 179 | 2 | GO:0097450 | |
| GeneOntologyCellularComponent | growth cone | 5.27e-03 | 245 | 179 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.63e-03 | 451 | 179 | 10 | GO:0014069 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 3.15e-14 | 17 | 149 | 9 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 3.67e-13 | 21 | 149 | 9 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 1.59e-12 | 24 | 149 | 9 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 5.54e-12 | 27 | 149 | 9 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 8.09e-12 | 28 | 149 | 9 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 2.30e-11 | 31 | 149 | 9 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 2.30e-11 | 31 | 149 | 9 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 7.76e-11 | 35 | 149 | 9 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 1.03e-10 | 36 | 149 | 9 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 2.25e-10 | 39 | 149 | 9 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 7.19e-10 | 44 | 149 | 9 | MP:0031023 | |
| MousePheno | polyphagia | 7.76e-10 | 80 | 149 | 11 | MP:0001433 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.34e-09 | 47 | 149 | 9 | MP:0031617 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.99e-09 | 49 | 149 | 9 | MP:0020948 | |
| MousePheno | obese | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CRTC1 BBS10 BBS7 PSG8 | 2.70e-09 | 113 | 149 | 12 | MP:0001261 |
| MousePheno | decreased cellular glucose uptake | 4.14e-09 | 53 | 149 | 9 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 4.92e-09 | 54 | 149 | 9 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.30e-08 | 60 | 149 | 9 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 1.51e-08 | 61 | 149 | 9 | MP:0010951 | |
| MousePheno | increased insulin secretion | 2.33e-08 | 64 | 149 | 9 | MP:0003058 | |
| MousePheno | abnormal carbon dioxide production | 3.52e-08 | 67 | 149 | 9 | MP:0008962 | |
| MousePheno | abnormal muscle cell glucose uptake | 3.52e-08 | 67 | 149 | 9 | MP:0004130 | |
| MousePheno | decreased energy expenditure | 5.48e-08 | 119 | 149 | 11 | MP:0004890 | |
| MousePheno | increased body size | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CRTC1 IDUA CLOCK BBS10 STARD5 PNPLA1 BBS7 SLC47A1 PSG8 KDM4B CDK4 | 7.03e-08 | 409 | 149 | 19 | MP:0001264 |
| MousePheno | abnormal vascular wound healing | 7.57e-08 | 73 | 149 | 9 | MP:0004883 | |
| MousePheno | increased circulating leptin level | 9.12e-08 | 125 | 149 | 11 | MP:0005669 | |
| MousePheno | abnormal cellular glucose uptake | 1.29e-07 | 102 | 149 | 10 | MP:0003925 | |
| MousePheno | decreased oxygen consumption | 1.52e-07 | 79 | 149 | 9 | MP:0005290 | |
| MousePheno | decreased susceptibility to Riboviria infection | 2.11e-07 | 82 | 149 | 9 | MP:0020914 | |
| MousePheno | abnormal insulin secretion | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK GEM SIDT2 PSG8 | 2.84e-07 | 171 | 149 | 12 | MP:0003564 |
| MousePheno | increased hormone level | WHRN PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LAMA2 CRTC1 CLOCK BBS10 SLC5A5 CLCN2 PAX8 SLC18A3 SPRYD3 LRP2 DIO3 PSG8 PLK4 ADGRL3 | 2.95e-07 | 641 | 149 | 23 | MP:0014454 |
| MousePheno | increased total tissue mass | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CRTC1 IDUA CLOCK BBS10 STARD5 BBS7 SLC47A1 PSG8 CDK4 | 3.36e-07 | 364 | 149 | 17 | MP:0012323 |
| MousePheno | increased body weight | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CRTC1 IDUA CLOCK BBS10 STARD5 BBS7 SLC47A1 PSG8 CDK4 | 3.36e-07 | 364 | 149 | 17 | MP:0001260 |
| MousePheno | abnormal glycogen homeostasis | 3.87e-07 | 144 | 149 | 11 | MP:0005438 | |
| MousePheno | abnormal endocrine pancreas secretion | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK GEM SIDT2 PSG8 | 3.87e-07 | 176 | 149 | 12 | MP:0014195 |
| MousePheno | abnormal pancreas secretion | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK GEM SIDT2 PSG8 | 5.89e-07 | 183 | 149 | 12 | MP:0002694 |
| MousePheno | increased food intake | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CRTC1 BBS10 BBS7 PSG8 | 8.31e-07 | 189 | 149 | 12 | MP:0011939 |
| MousePheno | increased circulating hormone level | WHRN PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LAMA2 CRTC1 CLOCK BBS10 SLC5A5 CLCN2 PAX8 SPRYD3 LRP2 DIO3 PSG8 PLK4 | 8.39e-07 | 578 | 149 | 21 | MP:0014456 |
| MousePheno | abnormal wound healing | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 DACT2 SORBS3 PSG8 | 1.04e-06 | 193 | 149 | 12 | MP:0005023 |
| MousePheno | abnormal pancreatic beta cell physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK GEM SIDT2 PSG8 | 1.22e-06 | 196 | 149 | 12 | MP:0003562 |
| MousePheno | abnormal endocrine pancreas physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CLOCK GEM SIDT2 PSG8 | 1.68e-06 | 202 | 149 | 12 | MP:0010147 |
| MousePheno | increased incidence of induced tumors | 2.39e-06 | 173 | 149 | 11 | MP:0002021 | |
| MousePheno | decreased respiratory quotient | 2.59e-06 | 110 | 149 | 9 | MP:0010379 | |
| MousePheno | increased incidence of tumors by chemical induction | 2.62e-06 | 141 | 149 | 10 | MP:0004499 | |
| MousePheno | abnormal hormone level | WHRN PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 TNC PSG9 PSG11 LAMA2 CRTC1 CLOCK SLC7A11 BBS10 SLC5A5 SIDT2 CLCN2 PAX8 PTPRS SLC18A3 SPRYD3 LRP2 DIO3 PSG8 PLK4 ADGRL3 CDK4 NPAS2 | 2.63e-06 | 1073 | 149 | 29 | MP:0003953 |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 5.33e-06 | 120 | 149 | 9 | MP:0009786 | |
| MousePheno | increased triglyceride level | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CRTC1 CLOCK SIDT2 PNPLA1 PSG8 PAX5 | 5.67e-06 | 354 | 149 | 15 | MP:0005317 |
| MousePheno | decreased susceptibility to viral infection | 7.45e-06 | 125 | 149 | 9 | MP:0002410 | |
| MousePheno | abnormal endocrine gland physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LAMA2 CLOCK GEM SIDT2 CLCN2 PAX8 PSG8 | 7.67e-06 | 363 | 149 | 15 | MP:0013561 |
| MousePheno | impaired glucose tolerance | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 CRTC1 SIRPA CLOCK GEM SIDT2 AGL PSG8 PAX5 | 1.42e-05 | 480 | 149 | 17 | MP:0005293 |
| MousePheno | abnormal pancreas physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CPA1 CLOCK GEM SIDT2 PSG8 | 1.46e-05 | 292 | 149 | 13 | MP:0002693 |
| MousePheno | abnormal circulating hormone level | WHRN PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LAMA2 CRTC1 CLOCK BBS10 SLC5A5 SIDT2 CLCN2 PAX8 PTPRS SPRYD3 LRP2 DIO3 PSG8 PLK4 CDK4 NPAS2 | 2.43e-05 | 954 | 149 | 25 | MP:0005418 |
| MousePheno | abnormal response to injury | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 DACT2 CR2 CLOCK AQP4 SORBS3 PSG8 MAPK1 ARHGAP21 NPAS2 MYBPC3 | 2.43e-05 | 607 | 149 | 19 | MP:0005164 |
| MousePheno | abnormal incidence of induced tumors | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 NBN SLC7A11 STRAP PSG8 | 3.09e-05 | 269 | 149 | 12 | MP:0013151 |
| MousePheno | abnormal colon morphology | 3.58e-05 | 152 | 149 | 9 | MP:0000495 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CR2 AQP4 AGBL4 PSG8 | 4.41e-05 | 279 | 149 | 12 | MP:0009785 |
| MousePheno | abnormal gland physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LAMA2 XIAP CPA1 CLOCK GEM SIDT2 CLCN2 PAX8 PXMP2 PSG8 KDM4B FOXC1 | 4.46e-05 | 691 | 149 | 20 | MP:0002164 |
| MousePheno | abnormal circulating leptin level | 4.49e-05 | 236 | 149 | 11 | MP:0005667 | |
| MousePheno | abnormal oxygen consumption | 4.51e-05 | 195 | 149 | 10 | MP:0005288 | |
| MousePheno | insulin resistance | 4.92e-05 | 197 | 149 | 10 | MP:0005331 | |
| MousePheno | abnormal eating behavior | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 SI CRTC1 DCC CLOCK BBS10 PNPLA1 BBS7 PSG8 SPAG17 ADGRL3 | 7.63e-05 | 604 | 149 | 18 | MP:0001431 |
| MousePheno | abnormal glucose tolerance | ABHD17A PDPR ATP5PO PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 SLC26A2 PSG9 PSG11 CRTC1 SIRPA CLOCK GEM BBS10 SIDT2 AGL PSG8 PAX5 | 9.12e-05 | 787 | 149 | 21 | MP:0005291 |
| MousePheno | increased lean body mass | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PUM2 DUSP26 AGL PSG8 DCLK2 | 1.06e-04 | 354 | 149 | 13 | MP:0003960 |
| MousePheno | absent uterine horn | 1.13e-04 | 2 | 149 | 2 | MP:0009215 | |
| MousePheno | abnormal respiratory quotient | 1.22e-04 | 178 | 149 | 9 | MP:0004129 | |
| MousePheno | abnormal consumption behavior | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 SI CRTC1 DCC CLOCK BBS10 PNPLA1 BBS7 PSG8 SPAG17 ADGRL3 CDK4 | 1.48e-04 | 695 | 149 | 19 | MP:0002069 |
| MousePheno | abnormal susceptibility to Riboviria infection | 1.70e-04 | 186 | 149 | 9 | MP:0020912 | |
| MousePheno | abnormal food intake | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CRTC1 CLOCK BBS10 PNPLA1 BBS7 PSG8 SPAG17 | 1.92e-04 | 481 | 149 | 15 | MP:0005449 |
| MousePheno | abnormal susceptibility to viral infection | 1.99e-04 | 279 | 149 | 11 | MP:0020185 | |
| MousePheno | abnormal gas homeostasis | WHRN PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 SLC5A7 NBEA TFRC ARG1 SLC18A3 LRP2 PSG8 SPAG17 | 2.23e-04 | 600 | 149 | 17 | MP:0003948 |
| MousePheno | increased circulating insulin level | 2.25e-04 | 283 | 149 | 11 | MP:0002079 | |
| MousePheno | abnormal physiological response to xenobiotic | MBTPS1 RBFOX3 MAOB PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 SLC5A7 CLOCK AQP4 SLC7A11 STRAP SLC47A1 PSG8 | 2.40e-04 | 662 | 149 | 18 | MP:0008872 |
| MousePheno | increased physiological sensitivity to xenobiotic | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 SLC7A11 SLC47A1 PSG8 | 2.46e-04 | 286 | 149 | 11 | MP:0008873 |
| MousePheno | increased lipid level | BOC MBTPS1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LAMA2 SI CRTC1 CLOCK SLC5A5 SIDT2 PNPLA1 AGL SPRYD3 PSG8 PAX5 | 2.52e-04 | 847 | 149 | 21 | MP:0014460 |
| MousePheno | abnormal blood vessel physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 AQP4 CLCN2 P2RX2 PSG8 FOXC1 | 3.04e-04 | 394 | 149 | 13 | MP:0000249 |
| MousePheno | failure of intramembranous bone ossification | 3.36e-04 | 3 | 149 | 2 | MP:0008276 | |
| MousePheno | absent efferent ductules of testis | 3.36e-04 | 3 | 149 | 2 | MP:0004729 | |
| MousePheno | increased Ly6C-positive mature NK cell number | 3.36e-04 | 3 | 149 | 2 | MP:0013676 | |
| MousePheno | abnormal vasculature physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 AQP4 CLCN2 P2RX2 PSG8 FOXC1 | 3.86e-04 | 404 | 149 | 13 | MP:0031170 |
| MousePheno | failure of bone ossification | 3.96e-04 | 14 | 149 | 3 | MP:0008274 | |
| MousePheno | absent corpus callosum | 3.99e-04 | 33 | 149 | 4 | MP:0002196 | |
| MousePheno | decreased susceptibility to infection | 4.06e-04 | 255 | 149 | 10 | MP:0002409 | |
| MousePheno | abnormal circulating triglyceride level | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CRTC1 CLOCK SIDT2 PCDH15 PSG8 PAX5 | 4.06e-04 | 516 | 149 | 15 | MP:0011969 |
| MousePheno | abnormal auditory brainstem response | WHRN LAMA2 IDUA AQP4 SLC7A11 PRSS36 SLC5A5 PITPNM1 PAX8 P2RX2 TMEM145 PCDH15 LRP2 LMAN2 PAX5 ARHGAP21 | 4.28e-04 | 576 | 149 | 16 | MP:0004738 |
| MousePheno | abnormal testis development | 4.48e-04 | 34 | 149 | 4 | MP:0003830 | |
| MousePheno | abnormal triglyceride level | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 SI CRTC1 CLOCK SIDT2 PNPLA1 PCDH15 PSG8 PAX5 | 4.62e-04 | 639 | 149 | 17 | MP:0000187 |
| MousePheno | abnormal muscle physiology | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CNTNAP1 LAMA2 CASP8 XIAP NBEA IDUA RYR3 FIG4 SLC18A3 AGL PCDH15 PSG8 MAPK1 MYBPC3 | 4.84e-04 | 954 | 149 | 22 | MP:0002106 |
| MousePheno | abnormal hearing physiology | WHRN LAMA2 IDUA AQP4 SLC7A11 PRSS36 SLC5A5 PITPNM1 PAX8 P2RX2 TMEM145 PCDH15 LRP2 LMAN2 PAX5 USH2A ARHGAP21 | 4.96e-04 | 643 | 149 | 17 | MP:0001963 |
| MousePheno | abnormal circulating pituitary hormone level | 5.10e-04 | 172 | 149 | 8 | MP:0005116 | |
| MousePheno | abnormal energy expenditure | 5.29e-04 | 313 | 149 | 11 | MP:0005450 | |
| MousePheno | abnormal hearing electrophysiology | WHRN LAMA2 IDUA AQP4 SLC7A11 PRSS36 SLC5A5 PITPNM1 PAX8 P2RX2 TMEM145 PCDH15 LRP2 LMAN2 PAX5 ARHGAP21 | 5.98e-04 | 594 | 149 | 16 | MP:0006335 |
| MousePheno | abnormal oviduct morphology | 6.00e-04 | 16 | 149 | 3 | MP:0003574 | |
| MousePheno | abnormal reproductive system development | 6.58e-04 | 99 | 149 | 6 | MP:0003936 | |
| MousePheno | abnormal energy homeostasis | 6.69e-04 | 322 | 149 | 11 | MP:0005448 | |
| MousePheno | increased circulating thyroid-stimulating hormone level | 7.23e-04 | 17 | 149 | 3 | MP:0005122 | |
| MousePheno | decreased circulating triglyceride level | 7.30e-04 | 275 | 149 | 10 | MP:0002644 | |
| MousePheno | abnormal spinal cord morphology | 7.93e-04 | 278 | 149 | 10 | MP:0000955 | |
| MousePheno | decreased circulating triiodothyronine level | 8.61e-04 | 18 | 149 | 3 | MP:0005479 | |
| MousePheno | abnormal cochlear labyrinth morphology | 9.35e-04 | 235 | 149 | 9 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 9.35e-04 | 235 | 149 | 9 | MP:0003169 | |
| Domain | V-set | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 TRB PSG9 PSG11 CEACAM3 SIRPA CEACAM19 CD101 PSG8 | 2.92e-11 | 184 | 180 | 16 | PF07686 |
| Domain | Ig-like_fold | BOC FLNB COL7A1 FN1 PSG1 PSG2 PSG3 PSG4 PSG5 COL20A1 PSG6 TNC PSG7 TRB PSG9 PSG11 CEACAM3 SIRPA DCC NOMO1 CEACAM19 NEO1 NOMO2 PTPRS CD101 PSG8 USH2A NOMO3 MYBPC3 | 3.81e-11 | 706 | 180 | 29 | IPR013783 |
| Domain | - | BOC FLNB COL7A1 FN1 PSG1 PSG2 PSG3 PSG4 PSG5 COL20A1 PSG6 TNC PSG7 PSG9 PSG11 CEACAM3 SIRPA DCC NOMO1 CEACAM19 NEO1 NOMO2 PTPRS CD101 PSG8 USH2A NOMO3 MYBPC3 | 4.54e-11 | 663 | 180 | 28 | 2.60.40.10 |
| Domain | Ig_V-set | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 TRB PSG9 PSG11 CEACAM3 SIRPA CEACAM19 CD101 PSG8 | 9.52e-11 | 199 | 180 | 16 | IPR013106 |
| Domain | Ig_2 | 1.04e-10 | 73 | 180 | 11 | PF13895 | |
| Domain | IGc2 | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 DCC NEO1 PTPRS PSG8 MYBPC3 | 9.04e-09 | 235 | 180 | 15 | SM00408 |
| Domain | Ig_sub2 | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 DCC NEO1 PTPRS PSG8 MYBPC3 | 9.04e-09 | 235 | 180 | 15 | IPR003598 |
| Domain | IG | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 TRB PSG9 PSG11 CEACAM3 SIRPA DCC NEO1 PTPRS CD101 PSG8 MYBPC3 | 2.65e-08 | 421 | 180 | 19 | SM00409 |
| Domain | Ig_sub | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 TRB PSG9 PSG11 CEACAM3 SIRPA DCC NEO1 PTPRS CD101 PSG8 MYBPC3 | 2.65e-08 | 421 | 180 | 19 | IPR003599 |
| Domain | Ig-like_dom | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 TRB PSG9 PSG11 CEACAM3 SIRPA DCC CEACAM19 NEO1 PTPRS CD101 PSG8 MYBPC3 | 9.00e-08 | 503 | 180 | 20 | IPR007110 |
| Domain | IG_LIKE | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 TRB PSG9 PSG11 CEACAM3 SIRPA DCC NEO1 PTPRS CD101 PSG8 MYBPC3 | 2.92e-07 | 491 | 180 | 19 | PS50835 |
| Domain | ig | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PTPRS PSG8 | 3.25e-07 | 190 | 180 | 12 | PF00047 |
| Domain | Immunoglobulin | BOC PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 PTPRS PSG8 | 3.25e-07 | 190 | 180 | 12 | IPR013151 |
| Domain | Pax2_C | 8.80e-07 | 3 | 180 | 3 | IPR022130 | |
| Domain | Pax2_C | 8.80e-07 | 3 | 180 | 3 | PF12403 | |
| Domain | DUF2012 | 3.50e-06 | 4 | 180 | 3 | PF09430 | |
| Domain | DUF2012 | 3.50e-06 | 4 | 180 | 3 | IPR019008 | |
| Domain | fn3 | 3.93e-06 | 162 | 180 | 10 | PF00041 | |
| Domain | FN3 | 1.27e-05 | 185 | 180 | 10 | SM00060 | |
| Domain | CarboxyPept-like_regulatory | 1.80e-05 | 17 | 180 | 4 | IPR008969 | |
| Domain | FN3 | 2.39e-05 | 199 | 180 | 10 | PS50853 | |
| Domain | FN3_dom | 3.63e-05 | 209 | 180 | 10 | IPR003961 | |
| Domain | Carb-bd-like_fold | 4.76e-05 | 8 | 180 | 3 | IPR013784 | |
| Domain | PAX | 7.09e-05 | 9 | 180 | 3 | SM00351 | |
| Domain | PAIRED_2 | 7.09e-05 | 9 | 180 | 3 | PS51057 | |
| Domain | PAIRED_1 | 7.09e-05 | 9 | 180 | 3 | PS00034 | |
| Domain | Paired_dom | 7.09e-05 | 9 | 180 | 3 | IPR001523 | |
| Domain | PAX | 7.09e-05 | 9 | 180 | 3 | PF00292 | |
| Domain | Neogenin_C | 9.24e-05 | 2 | 180 | 2 | IPR010560 | |
| Domain | Neogenin_C | 9.24e-05 | 2 | 180 | 2 | PF06583 | |
| Domain | FAM70 | 9.24e-05 | 2 | 180 | 2 | PF14967 | |
| Domain | FAM70 | 9.24e-05 | 2 | 180 | 2 | IPR028014 | |
| Domain | CarboxyPept_regulatory_dom | 2.34e-04 | 13 | 180 | 3 | IPR014766 | |
| Domain | - | 2.34e-04 | 13 | 180 | 3 | 2.60.40.1120 | |
| Domain | Gal_Lectin | 9.06e-04 | 5 | 180 | 2 | PF02140 | |
| Domain | Atypical_DUSP_famA | 9.06e-04 | 5 | 180 | 2 | IPR020405 | |
| Domain | Lectin_gal-bd_dom | 9.06e-04 | 5 | 180 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 9.06e-04 | 5 | 180 | 2 | PS50228 | |
| Domain | 6-blade_b-propeller_TolB-like | 9.93e-04 | 46 | 180 | 4 | IPR011042 | |
| Domain | ConA-like_dom | 1.31e-03 | 219 | 180 | 8 | IPR013320 | |
| Domain | CUB | 1.36e-03 | 50 | 180 | 4 | SM00042 | |
| Domain | - | 1.57e-03 | 52 | 180 | 4 | 2.60.120.290 | |
| Domain | CUB | 1.69e-03 | 53 | 180 | 4 | PS01180 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 CEACAM3 SIRPA ITGA5 SLC7A11 PSG8 | 7.67e-10 | 194 | 139 | 15 | M16312 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL7A1 FN1 PSG1 PSG2 PSG3 PSG4 PSG5 COL20A1 PSG6 TNC PSG9 PSG11 TMPRSS6 ITGA5 PSG8 PLOD2 | 5.06e-09 | 258 | 139 | 16 | MM14572 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 SIRPA ITGA5 SLC7A11 PSG8 | 5.17e-09 | 158 | 139 | 13 | MM14812 |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 5.55e-07 | 99 | 139 | 9 | MM14624 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.69e-05 | 188 | 139 | 10 | MM15828 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 ACLY PSG11 APEH SIRPA ARG1 RAB18 AGL PSG8 MAPK1 | 4.35e-05 | 511 | 139 | 16 | MM15330 |
| Pathway | REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM | 5.07e-05 | 8 | 139 | 3 | M48014 | |
| Pubmed | 3.52e-20 | 15 | 182 | 10 | 25490771 | ||
| Pubmed | Disruption of Nectin-like 1 cell adhesion molecule leads to delayed axonal myelination in the CNS. | 1.06e-18 | 19 | 182 | 10 | 19036974 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.69e-18 | 13 | 182 | 9 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.69e-18 | 13 | 182 | 9 | 19273835 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 20044046 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 32150576 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.69e-18 | 13 | 182 | 9 | 12832451 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 25406283 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 8380065 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 1279194 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 25724769 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.69e-18 | 13 | 182 | 9 | 22092845 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.69e-18 | 13 | 182 | 9 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.69e-18 | 13 | 182 | 9 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.69e-18 | 13 | 182 | 9 | 23800882 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.69e-18 | 13 | 182 | 9 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.69e-18 | 13 | 182 | 9 | 39168268 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 8402684 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.69e-18 | 13 | 182 | 9 | 21949477 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 26219866 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 2133556 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.69e-18 | 13 | 182 | 9 | 19358828 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.69e-18 | 13 | 182 | 9 | 34058224 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.69e-18 | 13 | 182 | 9 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.69e-18 | 13 | 182 | 9 | 25972571 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.69e-18 | 13 | 182 | 9 | 15220458 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 18843289 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 15207636 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 21081647 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 11133662 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 11483763 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 18003729 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.69e-18 | 13 | 182 | 9 | 27695943 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.69e-18 | 13 | 182 | 9 | 16638824 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.69e-18 | 13 | 182 | 9 | 21670291 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 22162753 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 2702644 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 11801635 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 21760897 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 1719235 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 16619040 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.69e-18 | 13 | 182 | 9 | 8209741 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 32521208 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.69e-18 | 13 | 182 | 9 | 29967450 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 1653760 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 32169849 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.69e-18 | 13 | 182 | 9 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.69e-18 | 13 | 182 | 9 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.69e-18 | 13 | 182 | 9 | 15316023 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 15331748 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.69e-18 | 13 | 182 | 9 | 22406619 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 7628460 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 19008452 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 2164599 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 29396368 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.69e-18 | 13 | 182 | 9 | 33352461 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 38381498 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 1633107 | ||
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.69e-18 | 13 | 182 | 9 | 32027621 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.69e-18 | 13 | 182 | 9 | 27777319 | |
| Pubmed | 1.69e-18 | 13 | 182 | 9 | 18848945 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 4.72e-18 | 14 | 182 | 9 | 34666041 | |
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 34619794 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 8896983 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 22962327 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 17623671 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 4.72e-18 | 14 | 182 | 9 | 18794798 | |
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 23469261 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 18454175 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 29907459 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 36719377 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 28567513 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 8207827 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 19700760 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 9212243 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 1648219 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 14517298 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 25908210 | ||
| Pubmed | 4.72e-18 | 14 | 182 | 9 | 9047385 | ||
| Interaction | PSG4 interactions | 2.63e-09 | 8 | 176 | 5 | int:PSG4 | |
| Interaction | PSG1 interactions | 2.88e-07 | 51 | 176 | 7 | int:PSG1 | |
| Cytoband | 19q13.2 | PSG1 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 CEACAM3 TMEM145 PSG8 | 6.41e-11 | 164 | 181 | 11 | 19q13.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 CEACAM3 USP29 CEACAM19 SUPT5H TMEM145 PSG8 | 8.45e-05 | 1192 | 181 | 15 | chr19q13 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | ABHD17A POLRMT CRTC1 UPF1 TRIP10 FCHO1 SLC5A5 WIZ P2RY11 PTPRS KDM4B | 3.52e-04 | 797 | 181 | 11 | chr19p13 |
| Cytoband | 1p36.12 | 4.96e-04 | 39 | 181 | 3 | 1p36.12 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 3.33e-21 | 11 | 132 | 10 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 CEACAM3 SIRPA CEACAM19 CD101 PSG8 | 2.05e-10 | 163 | 132 | 13 | 590 |
| GeneFamily | Fibronectin type III domain containing | 2.75e-07 | 160 | 132 | 10 | 555 | |
| GeneFamily | Paired boxes | 3.09e-05 | 9 | 132 | 3 | 675 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 3.14e-04 | 4 | 132 | 2 | 1244 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.18e-03 | 161 | 132 | 6 | 593 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 2.42e-14 | 35 | 177 | 10 | MM757 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 5.84e-13 | 32 | 177 | 9 | MM2 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | COL7A1 FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 TNC PSG9 PSG11 SIRPA PSG8 PLOD2 | 2.74e-11 | 182 | 177 | 14 | MM993 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 3.18e-11 | 48 | 177 | 9 | MM531 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 3.68e-11 | 93 | 177 | 11 | M40279 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 3.90e-10 | 87 | 177 | 10 | MM851 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.20e-09 | 128 | 177 | 11 | MM1000 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 2.04e-09 | 75 | 177 | 9 | MM605 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | BOC COL7A1 FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 TNC PSG9 PSG11 PSG8 ARHGAP21 | 9.25e-09 | 284 | 177 | 14 | MM987 |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | B3GALT1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 SRD5A1 SLC47A1 PSG8 | 1.33e-08 | 201 | 177 | 12 | MM1294 |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 DACT2 LRP2 PSG8 | 4.42e-08 | 224 | 177 | 12 | M40145 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 5.90e-08 | 230 | 177 | 12 | MM986 | |
| Coexpression | GSE30083_SP2_VS_SP4_THYMOCYTE_UP | BOC WHRN SRD5A1 PKD1L2 ABHD17C DUSP26 NEO1 TENM4 MAPK12 HHAT LRP2 | 1.25e-07 | 200 | 177 | 11 | M5034 |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 3.12e-07 | 219 | 177 | 11 | MM3826 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 3.59e-07 | 135 | 177 | 9 | MM965 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 5.84e-07 | 143 | 177 | 9 | MM989 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 1.19e-06 | 201 | 177 | 10 | MM1006 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 1.42e-06 | 159 | 177 | 9 | MM760 | |
| Coexpression | HENDRICKS_SMARCA4_TARGETS_UP | 1.72e-06 | 54 | 177 | 6 | M15057 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 ACLY PSG11 PSMB5 SIRPA ARG1 LRP2 PSG8 MAPK1 | 3.76e-06 | 534 | 177 | 15 | MM1050 |
| Coexpression | DESCARTES_FETAL_EYE_ASTROCYTES | 6.34e-06 | 39 | 177 | 5 | M40188 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 7.10e-06 | 302 | 177 | 11 | MM16604 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | ABHD17A PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 ACLY PSG11 PUM2 SIDT2 MAPK12 SLC25A38 PSG8 | 7.88e-06 | 568 | 177 | 15 | MM3824 |
| Coexpression | ZHANG_UTERUS_C7_EPITHELIAL2_CELL | ATP5PO NAAA COA3 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PSMB5 STRAP UCHL5 NAXD LMAN2 PSG8 RPL11 | 8.54e-06 | 799 | 177 | 18 | MM16613 |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | DCHS2 MAN1C1 OXCT2 DCC IL17D CSMD2 CR2 TMEM255B RYR3 PAX8 HHAT PXMP2 LRP2 DIO3 DCLK2 PAX2 PAX5 KLHL14 ADGRL3 FOXC1 NPAS2 | 2.22e-05 | 1115 | 177 | 21 | M10371 |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 2.23e-05 | 171 | 177 | 8 | M40134 | |
| Coexpression | GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP | 3.81e-05 | 135 | 177 | 7 | M8793 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 YIPF4 SIRPA TFRC TENM4 CCDC71 EML5 PSG8 FOXC1 | 4.59e-05 | 741 | 177 | 16 | MM1037 |
| Coexpression | GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP | 6.77e-05 | 200 | 177 | 8 | M4084 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 6.86e-05 | 102 | 177 | 6 | M10290 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 LAMA2 SIRPA TFRC CCDC71 EML5 PSG8 ALOX5AP | 7.89e-05 | 694 | 177 | 15 | MM1039 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 YIPF4 CNTNAP1 SIRPA TFRC MAPK12 EML5 SORBS3 PSG8 HNRNPR | 9.14e-05 | 871 | 177 | 17 | MM1005 |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | ABHD17A PDPR COA3 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG9 PSG11 PSMB5 CLOCK CCDC71 AGL LMAN2 PSG8 LTBR DCBLD2 | 1.50e-04 | 1088 | 177 | 19 | MM3699 |
| Coexpression | DESCARTES_FETAL_STOMACH_PARIETAL_AND_CHIEF_CELLS | 1.84e-04 | 42 | 177 | 4 | M40300 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 1.92e-04 | 17 | 177 | 3 | M47995 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 1.96e-04 | 436 | 177 | 11 | MM1326 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | DCHS2 OXCT2 DCC RYR3 SLC5A5 EML5 PAX8 SLC18A3 HHAT PXMP2 LRP2 DIO3 DCLK2 PAX2 PAX5 TMEM255A ADGRL3 NPAS2 | 2.37e-04 | 1035 | 177 | 18 | M9898 |
| CoexpressionAtlas | placenta | FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 DACT2 LAMA2 DIO3 PSG8 | 1.03e-06 | 349 | 172 | 14 | placenta |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | BOC WHRN FN1 PSG5 TMPRSS6 SLC5A7 CPA1 DCC IDUA DNAI3 TENM4 OLFML1 SLC18A3 HHAT PCDH19 LRP2 DIO3 DCLK2 PAX5 SPAG17 DNAH6 SH3RF3 TMEM255A FOXC1 | 8.60e-06 | 1094 | 172 | 24 | ratio_EB_vs_SC_2500_K3 |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | PSG2 PSG3 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 ITGA5 TMEM255B PSG8 | 1.04e-11 | 136 | 181 | 11 | 2c723777fadc5946df67d3e992471d8134b827f4 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-08 | 183 | 181 | 9 | 99bb4ceb92f6467f2359a42ab2cff6df18825a30 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-08 | 184 | 181 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-08 | 184 | 181 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-08 | 184 | 181 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 9.29e-08 | 191 | 181 | 9 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.80e-07 | 149 | 181 | 8 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.00e-07 | 178 | 181 | 8 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.98e-07 | 184 | 181 | 8 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.06e-06 | 188 | 181 | 8 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.30e-06 | 146 | 181 | 7 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Control-Endothelial-Epi-like-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-06 | 157 | 181 | 7 | 2c369660c752c0fb3bd798a561d3359e2f9aa983 | |
| ToppCell | Control-Endothelial-Epi-like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-06 | 157 | 181 | 7 | 4d02c50d5d1b892ea241e98724386d8a5a156a46 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Chat.Synpr-Slc5a7_(Cholinergic_cortical__interneurons)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 62 | 181 | 5 | d63e8417192ebe5d44f0868c5991d28c83bfd75d | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Chat.Synpr-Slc5a7_(Cholinergic_cortical__interneurons)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 62 | 181 | 5 | faf2f54e6ddb34f342ce18470fb44b3a5b1d4139 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-06 | 166 | 181 | 7 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-06 | 166 | 181 | 7 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-06 | 169 | 181 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | primary_visual_cortex-Non-neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.88e-06 | 176 | 181 | 7 | 2c92f3f55d668cfe80051b5128160a6dc3aec4e8 | |
| ToppCell | frontal_cortex-Non-neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.80e-06 | 179 | 181 | 7 | ef01478bd03eb00f0ff2b6a8ae9244687c5f85aa | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.46e-06 | 181 | 181 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-06 | 182 | 181 | 7 | 904804813849b7f7f716ba1554d33b07bc0a701e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.81e-06 | 182 | 181 | 7 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.81e-06 | 182 | 181 | 7 | 5d8b7fe18286e27f0f50c5d2d9be56850e2cb8f4 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 183 | 181 | 7 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-05 | 185 | 181 | 7 | 7925519b855f76444a0b57382ce35d89457b0b14 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.13e-05 | 186 | 181 | 7 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.17e-05 | 187 | 181 | 7 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.17e-05 | 187 | 181 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-05 | 189 | 181 | 7 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-05 | 191 | 181 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-05 | 194 | 181 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.48e-05 | 194 | 181 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 194 | 181 | 7 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.53e-05 | 195 | 181 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.53e-05 | 195 | 181 | 7 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 130 | 181 | 6 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 196 | 181 | 7 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 197 | 181 | 7 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.64e-05 | 197 | 181 | 7 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.64e-05 | 197 | 181 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | distal-1-mesenchymal-Alveolar_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-05 | 198 | 181 | 7 | 6594c35ab203dc51462167c61807b0d49fa30fb2 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.75e-05 | 199 | 181 | 7 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 199 | 181 | 7 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-05 | 199 | 181 | 7 | 8e9862907b15809d083216e7d6a0f435015e5d15 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-05 | 199 | 181 | 7 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-05 | 200 | 181 | 7 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.81e-05 | 200 | 181 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-05 | 200 | 181 | 7 | 0f4b8b0868bda406fe6bf01d1b722510fdfd0168 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.81e-05 | 200 | 181 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-05 | 200 | 181 | 7 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.81e-05 | 200 | 181 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.81e-05 | 200 | 181 | 7 | bc969a956f62570419a5faaf0ab0fd17b343c5ca | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.81e-05 | 200 | 181 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | Severe-B_intermediate-14|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.54e-05 | 142 | 181 | 6 | f9cbc266fcea19bec504be4f3a28d1173c6b2e3c | |
| ToppCell | Severe-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.54e-05 | 142 | 181 | 6 | 9c7d5783302974b883bd887f997d094eb5925ec2 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.75e-05 | 144 | 181 | 6 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.58e-05 | 151 | 181 | 6 | 7e5e35ce601ca3d3722063566e89664909171b8d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.58e-05 | 151 | 181 | 6 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.86e-05 | 153 | 181 | 6 | 95b28c5bd10ffb74c0993ebd565038b9818e4bd2 | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.86e-05 | 153 | 181 | 6 | 3ab9d55b3db51715c1d61eca142384195ce4b54f | |
| ToppCell | primary_visual_cortex-Non-neuronal-astrocyte-Astro|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.86e-05 | 153 | 181 | 6 | b09f8def40a1ea56722f3398f61a036667b61cd9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.30e-05 | 156 | 181 | 6 | e0aef6104be16b12304b8e30358f444c1660e92f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.30e-05 | 156 | 181 | 6 | 5b2781d38a83b4b0f8a53cf321ce5db3a07d0818 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 4.78e-05 | 159 | 181 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 160 | 181 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.95e-05 | 160 | 181 | 6 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.95e-05 | 160 | 181 | 6 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 160 | 181 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Influenza_Severe-cDC|Influenza_Severe / Disease group and Cell class | 6.08e-05 | 166 | 181 | 6 | b40bdf0f7f381e25be61188e9f6c294d25a8b824 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Stem_cells-neuroepithelial-like_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 6.28e-05 | 167 | 181 | 6 | e488d9c7cf4355959e3833de3bd496c13fc11b1b | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|World / disease group, cell group and cell class (v2) | 6.28e-05 | 167 | 181 | 6 | bf08f17965a4dd03f371b4ed0ab0d5e62ed61307 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.71e-05 | 169 | 181 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.93e-05 | 170 | 181 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 170 | 181 | 6 | 833b4f44ea1fa673dfc6b43ce45a79fe68ae3b05 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-05 | 171 | 181 | 6 | 5b74df72e36ad04dfb25c72f1ca8efe043f6cda6 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.16e-05 | 171 | 181 | 6 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.16e-05 | 171 | 181 | 6 | 41932c9e70829ee3d55ca5fdb74d290fc8229416 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.39e-05 | 172 | 181 | 6 | df3800bcd9777d02900eba0cfc26ab73de8a1d95 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 7.64e-05 | 173 | 181 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_T_(gd)|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.64e-05 | 173 | 181 | 6 | 62f2f42f54c9c6941bf888956be40230f92c883e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 173 | 181 | 6 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-05 | 173 | 181 | 6 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.88e-05 | 174 | 181 | 6 | 32fdeeebeeeca657eac6329caad4c28ca54e4d1c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.88e-05 | 174 | 181 | 6 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-myofibroblast_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.88e-05 | 174 | 181 | 6 | eb8012823b08729b462d1e5212f4873bb6b4eb1e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-05 | 176 | 181 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.39e-05 | 176 | 181 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 8.39e-05 | 176 | 181 | 6 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.66e-05 | 177 | 181 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.66e-05 | 177 | 181 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.93e-05 | 178 | 181 | 6 | 9fc5688cf705a74398d24e10e0aab4758612e72b | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.93e-05 | 178 | 181 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-05 | 178 | 181 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.44e-05 | 112 | 181 | 5 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 180 | 181 | 6 | f6a05b3751b01e74b2de8440801b0eb2e723c199 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-05 | 180 | 181 | 6 | dfc75ae4395ff46fbec2c54915d98ead5a1ba1a1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.79e-05 | 181 | 181 | 6 | 51836cdc66e42f04ed6a3c167cd6a3a67428c9f7 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 9.79e-05 | 181 | 181 | 6 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.79e-05 | 181 | 181 | 6 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| Computational | Neighborhood of CDKN1C | 2.70e-10 | 27 | 116 | 8 | GNF2_CDKN1C | |
| Computational | Neighborhood of MMP11 | 4.80e-10 | 42 | 116 | 9 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.14e-09 | 46 | 116 | 9 | GNF2_TIMP2 | |
| Computational | Neighborhood of EGFR | 1.22e-09 | 32 | 116 | 8 | GNF2_EGFR | |
| Computational | Neighborhood of KISS1 | 2.08e-09 | 49 | 116 | 9 | GNF2_KISS1 | |
| Computational | Neighborhood of IGFBP1 | 2.66e-09 | 35 | 116 | 8 | GNF2_IGFBP1 | |
| Computational | Adhesion molecules. | 2.07e-05 | 141 | 116 | 9 | MODULE_122 | |
| Drug | Rgd Peptide | BOC RNGTT FN1 PSG1 PSG2 PSG3 PSG4 PSG5 PSG6 TNC PSG7 PSG9 PSG11 CASP8 ITGA5 PSG8 LTBR MAPK1 DCBLD2 PLK4 | 4.22e-15 | 239 | 179 | 20 | CID000104802 |
| Drug | AC1L1IPV | 2.41e-14 | 43 | 179 | 11 | CID000004683 | |
| Drug | pP-8 | 7.48e-07 | 10 | 179 | 4 | CID000444681 | |
| Drug | Didemnins | 3.48e-06 | 14 | 179 | 4 | CID000123844 | |
| Drug | Sulindac [38194-50-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.80e-06 | 197 | 179 | 10 | 5528_UP | |
| Drug | Ajmaline [4360-12-7]; Up 200; 12.2uM; HL60; HG-U133A | CNTNAP1 LAMA2 CRTC1 DUSP26 SLC8B1 WIZ EFNB3 TECPR2 SORBS3 MYBPC3 | 3.80e-06 | 197 | 179 | 10 | 1749_UP |
| Drug | AC1NRATE | 4.14e-06 | 83 | 179 | 7 | CID005288086 | |
| Drug | Nebeldose | 7.64e-06 | 60 | 179 | 6 | CID000165707 | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.38e-05 | 181 | 179 | 9 | 1537_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.30e-05 | 193 | 179 | 9 | 3344_UP | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.50e-05 | 195 | 179 | 9 | 2223_DN | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 2.50e-05 | 195 | 179 | 9 | 5399_DN | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.50e-05 | 195 | 179 | 9 | 4960_UP | |
| Drug | Lactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | 2.60e-05 | 196 | 179 | 9 | 6605_DN | |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.60e-05 | 196 | 179 | 9 | 5642_UP | |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.05e-05 | 200 | 179 | 9 | 6075_UP | |
| Drug | YIGSR | 3.75e-05 | 79 | 179 | 6 | CID000123977 | |
| Drug | benzil | 4.11e-05 | 25 | 179 | 4 | CID000008651 | |
| Drug | bromodeoxyuridine | FN1 PSG1 PSG2 PSG4 PSG5 PSG6 TNC PSG7 AQP4 MAPK1 DCBLD2 CDK4 | 4.52e-05 | 376 | 179 | 12 | CID000006035 |
| Disease | cD177 antigen measurement | 3.43e-16 | 18 | 175 | 9 | EFO_0021866 | |
| Disease | Usher Syndrome, Type II | 2.03e-06 | 5 | 175 | 3 | C1568249 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 4.05e-06 | 6 | 175 | 3 | EFO_0801907 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 7.05e-06 | 7 | 175 | 3 | EFO_0801906 | |
| Disease | atelosteogenesis (is_implicated_in) | 3.50e-05 | 2 | 175 | 2 | DOID:0050648 (is_implicated_in) | |
| Disease | Atelosteogenesis | 3.50e-05 | 2 | 175 | 2 | cv:C5574658 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 3 in blood serum | 3.50e-05 | 2 | 175 | 2 | OBA_2043058 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 4 in blood serum | 3.50e-05 | 2 | 175 | 2 | OBA_2043059 | |
| Disease | Disorder of eye | 4.14e-05 | 212 | 175 | 8 | C0015397 | |
| Disease | Schizophrenia | SYN3 MAOB LAMA2 DCC CSMD2 CLOCK AQP4 PITPNM1 TENM4 EML5 HHAT LRP2 DIO3 MAPK1 KIF17 NPAS2 | 7.86e-05 | 883 | 175 | 16 | C0036341 |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 2.08e-04 | 4 | 175 | 2 | EFO_0801909 | |
| Disease | cerebral amyloid angiopathy (is_marker_for) | 2.08e-04 | 4 | 175 | 2 | DOID:9246 (is_marker_for) | |
| Disease | Weissenbacher-Zweymuller syndrome (implicated_via_orthology) | 2.08e-04 | 4 | 175 | 2 | DOID:4258 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (is_implicated_in) | 2.08e-04 | 4 | 175 | 2 | DOID:0050328 (is_implicated_in) | |
| Disease | Iron deficiency anemia | 2.08e-04 | 4 | 175 | 2 | C0162316 | |
| Disease | Ciliopathies | 5.13e-04 | 110 | 175 | 5 | C4277690 | |
| Disease | Eye Diseases, Hereditary | 5.16e-04 | 6 | 175 | 2 | C0015398 | |
| Disease | Hereditary retinal dystrophy | 7.20e-04 | 7 | 175 | 2 | C0154860 | |
| Disease | melanoma | 7.27e-04 | 248 | 175 | 7 | C0025202 | |
| Disease | breast cancer (is_marker_for) | 8.54e-04 | 185 | 175 | 6 | DOID:1612 (is_marker_for) | |
| Disease | Alzheimer's disease (is_marker_for) | 8.96e-04 | 257 | 175 | 7 | DOID:10652 (is_marker_for) | |
| Disease | Lymphoma, Non-Hodgkin | 8.96e-04 | 32 | 175 | 3 | C0024305 | |
| Disease | breast ductal carcinoma (is_marker_for) | 9.57e-04 | 8 | 175 | 2 | DOID:3007 (is_marker_for) | |
| Disease | Colorectal Carcinoma | BOC COL7A1 FN1 RBP3 CASP8 DCC TFRC STRAP PAX8 PTPRS LRP2 SPAG17 | 1.04e-03 | 702 | 175 | 12 | C0009402 |
| Disease | Colorectal Neoplasms | 1.38e-03 | 277 | 175 | 7 | C0009404 | |
| Disease | Nonsyndromic Deafness | 1.39e-03 | 81 | 175 | 4 | C3711374 | |
| Disease | age at menarche, spine bone mineral density | 1.53e-03 | 10 | 175 | 2 | EFO_0004703, EFO_0007701 | |
| Disease | hip bone mineral density, age at menarche | 1.53e-03 | 10 | 175 | 2 | EFO_0004703, EFO_0007702 | |
| Disease | short-term memory | 1.53e-03 | 83 | 175 | 4 | EFO_0004335 | |
| Disease | lung cancer (is_marker_for) | 1.60e-03 | 39 | 175 | 3 | DOID:1324 (is_marker_for) | |
| Disease | Kidney Neoplasm | 1.72e-03 | 40 | 175 | 3 | C0022665 | |
| Disease | Glioma | 1.81e-03 | 87 | 175 | 4 | C0017638 | |
| Disease | smoking status measurement, forced expiratory volume | 1.86e-03 | 11 | 175 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | hypertension (biomarker_via_orthology) | 2.42e-03 | 227 | 175 | 6 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of kidney | 2.42e-03 | 45 | 175 | 3 | C0740457 | |
| Disease | hearing impairment | 2.80e-03 | 98 | 175 | 4 | C1384666 | |
| Disease | iron biomarker measurement, transferrin saturation measurement | 3.04e-03 | 14 | 175 | 2 | EFO_0004461, EFO_0006333 | |
| Disease | Bardet-Biedl syndrome (is_implicated_in) | 3.04e-03 | 14 | 175 | 2 | DOID:1935 (is_implicated_in) | |
| Disease | cerebellum cortex volume change measurement | 3.04e-03 | 14 | 175 | 2 | EFO_0021497 | |
| Disease | transferrin receptor protein 1 measurement | 3.04e-03 | 14 | 175 | 2 | EFO_0802142 | |
| Disease | cholestasis (biomarker_via_orthology) | 3.09e-03 | 49 | 175 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | L2 Acute Lymphoblastic Leukemia | 3.28e-03 | 50 | 175 | 3 | C0023453 | |
| Disease | Childhood Acute Lymphoblastic Leukemia | 3.66e-03 | 52 | 175 | 3 | C0023452 | |
| Disease | Huntington's disease (is_marker_for) | 3.86e-03 | 53 | 175 | 3 | DOID:12858 (is_marker_for) | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 3.97e-03 | 16 | 175 | 2 | C0751885 | |
| Disease | transferrin saturation measurement | 3.97e-03 | 16 | 175 | 2 | EFO_0006333 | |
| Disease | Seasonal Affective Disorder | 3.97e-03 | 16 | 175 | 2 | C0085159 | |
| Disease | Mental Depression | 4.19e-03 | 254 | 175 | 6 | C0011570 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 4.49e-03 | 17 | 175 | 2 | C0751883 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 4.49e-03 | 17 | 175 | 2 | C2936862 | |
| Disease | Astrocytosis | 4.49e-03 | 17 | 175 | 2 | C3887640 | |
| Disease | Gliosis | 4.49e-03 | 17 | 175 | 2 | C0017639 | |
| Disease | Bardet-Biedl syndrome | 5.03e-03 | 18 | 175 | 2 | cv:C0752166 | |
| Disease | prostate cancer (is_implicated_in) | 5.27e-03 | 117 | 175 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 5.60e-03 | 19 | 175 | 2 | C0751884 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 5.60e-03 | 19 | 175 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 5.60e-03 | 19 | 175 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 5.74e-03 | 61 | 175 | 3 | C1961102 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLGERTQSTPGYIFG | 101 | P20292 | |
| GPIIGAVLAGGLYEY | 236 | P55087 | |
| IEGQYGTLQAYVTPR | 461 | Q8IWZ6 | |
| GYRGPVYNVTGEEVS | 1071 | P78357 | |
| GRTYSAPLIGVYHGT | 811 | Q7Z408 | |
| GQYVGSDGVVLSPNY | 1621 | Q7Z408 | |
| GRYIYISGGTTEQIS | 326 | Q13939 | |
| TVYSVGGSIAPRRYV | 376 | Q13939 | |
| IQIGNTYEGRPIYVL | 146 | P15085 | |
| YRAPELLVGDTQYGS | 166 | Q5MAI5 | |
| GTLYATTPGGTRIIY | 26 | O60516 | |
| RYFTGYVINGGPIRD | 201 | Q9Y5Z6 | |
| YYQLGRGSSDGFIVP | 1411 | Q9HAR2 | |
| RYGISPDSIILYGQS | 176 | Q96GS6 | |
| TRPGVFYIGREDGYI | 726 | Q8IWG1 | |
| QESRRGLPLTGEYYV | 1371 | Q6W2J9 | |
| PDLVSYYAGVNGISV | 316 | Q8TAM1 | |
| PVQVYGIEGRYATAL | 31 | P48047 | |
| TPVVGGLTYREGLYI | 246 | P05089 | |
| PSGAIEIRFYATGYI | 481 | Q16853 | |
| RTLTPSYYRGAQGVI | 71 | Q9NP72 | |
| SGGYTVIPFYRGERI | 286 | P69849 | |
| ILGRYYETGSIRPGV | 61 | Q06710 | |
| TPYYNVEIVATDGGG | 311 | Q9Y5E4 | |
| VVGAVYGPEFYAVTG | 196 | A6NFN3 | |
| APTAYYDQTGALVVG | 436 | Q8TB72 | |
| SGNTYYRVVLIGEQG | 71 | P55040 | |
| RYYETGSIKPGVIGG | 71 | Q02548 | |
| IIGYLPFEVLGTSGY | 271 | Q99743 | |
| VKYVDLGGSYVGPTQ | 51 | P27338 | |
| GTAEVYIPRNSGIGY | 571 | Q8TAB3 | |
| YIPRNSGIGYLVTVV | 576 | Q8TAB3 | |
| TQVSVEYGYRPGATA | 766 | O14526 | |
| VGPRYTNLSYIGEGA | 21 | P28482 | |
| PNIVVRGYIIGYGVG | 751 | P43146 | |
| GYGVGSPYAETVRVD | 761 | P43146 | |
| SGGYTVIPFYRGERI | 286 | Q5JPE7 | |
| VSYGYIGATILRVPS | 216 | Q8NGS2 | |
| ATAALELGPYVGYQV | 291 | Q96G91 | |
| TVGYGYIYPVTRLGK | 116 | Q7Z418 | |
| QLPGGNVTITYSYAG | 106 | Q7Z4F1 | |
| LETYVARSVGTRGPY | 221 | Q3ZCV2 | |
| DITGVRLPTGYYFGA | 241 | Q12907 | |
| LLPQNVGLLYVGGYE | 481 | O60942 | |
| YQIPAEGGGRIVLYG | 831 | Q14703 | |
| PYYVGLGVEATLKRG | 311 | P61550 | |
| VYYIVGGTSPREGVV | 246 | Q02083 | |
| YQGGRGPDGYQVSEL | 271 | P55073 | |
| TYVAPEIIAETGYGL | 556 | Q8N568 | |
| PGTYVIYVRFGGVDI | 1681 | O75369 | |
| GEPIYRNGQYVGKTT | 786 | Q8NCN5 | |
| YTLDVTTGQRKYGGP | 136 | O43390 | |
| SGGYTVIPFYRGERI | 286 | Q15155 | |
| RNYGGVYVGLPSEAV | 36 | Q8TAD7 | |
| IGVVGGCQEYTGAPY | 76 | Q8IW45 | |
| IPPTYRGVRYIDGGF | 161 | Q8N8W4 | |
| GTIIEGVNTPYLYFG | 166 | O94953 | |
| GVVIEGVNTPYLYFG | 166 | B2RXH2 | |
| GFSTYNPQVIIRGGT | 1266 | P24043 | |
| YVGGLPINYTTRRIG | 2886 | P24043 | |
| GGRSVYTEAYVTIPV | 151 | Q8TAD2 | |
| IGLSVVYYTVRGEGS | 4096 | P98164 | |
| LGPNGLVSYYIVASD | 481 | Q9Y5G1 | |
| VLYVVYSTGGQGPHR | 326 | Q6UWY5 | |
| RYYETGSIKPGVIGG | 71 | Q02962 | |
| SGGFIGYAPYVNRIV | 166 | O00469 | |
| LRFGEGVYYLTVVPE | 1246 | Q7Z442 | |
| LTVYRGGGYVVPLGT | 2096 | Q7Z442 | |
| RYSIGGLSPNSEYEI | 386 | Q13332 | |
| GIYGTVAYELIPGNV | 801 | Q6V1P9 | |
| LIRYVYIPVGGSQHG | 346 | Q5VTY9 | |
| GSTTVPYIEVYLGRA | 636 | Q5K4E3 | |
| GNGLRTGRCVPYYQG | 151 | Q9UBL9 | |
| AGVPKGNLTYGYVTI | 291 | P08648 | |
| TGVIYVNGPLDYETR | 1086 | Q96QU1 | |
| IGIITPYEGQRSYLV | 801 | Q92900 | |
| LYSSVGDLRPGQYGQ | 121 | Q5T0Z8 | |
| PYTLNILRGYGISGF | 351 | P0CF75 | |
| QPTILRSGDVYGYSS | 61 | Q8IV32 | |
| ALIYITGEITYGGRV | 3741 | Q9C0G6 | |
| DGIVQLGASYGVPSY | 466 | Q93033 | |
| LYVIGGRNETGYLSS | 426 | Q9P2G3 | |
| TCLGPNIYVTGGYRT | 316 | Q8NBE8 | |
| VSGYSGRVYERPVAG | 701 | Q9BWV1 | |
| RQDLVSQGGREVYPY | 261 | Q5SW24 | |
| NGRISYYSTPIAVGT | 31 | P20023 | |
| PYREEQGSGGYSLEI | 431 | Q96AV8 | |
| YEPVAEIGVGAYGTV | 6 | P11802 | |
| LQLGPSRGQYYGGSL | 51 | Q6UUV9 | |
| EYLVSVFPIYEGGVG | 441 | Q9P218 | |
| GSYSSYVQVRGSVPL | 316 | Q92562 | |
| PGVDYTITVYAVTGR | 1601 | P02751 | |
| VRSYTITGLQPGTDY | 1956 | P02751 | |
| NSLGVVPYLGGEQSY | 11 | Q12948 | |
| IGGNVSKYIVLPTGY | 21 | Q5VU57 | |
| TRYGVSPENIILYGQ | 196 | Q6PCB6 | |
| GRDVQGYYPGQLARL | 26 | Q5SVJ3 | |
| TYGGTRLFTYIPGIQ | 71 | Q7Z692 | |
| GYVIGTQQATPGAAY | 81 | P40198 | |
| GLGIGALVLAIYGYT | 61 | Q9Y2R0 | |
| GIIYGTDGQEAPIYE | 321 | Q14790 | |
| GPGLVYVTRYLDNGL | 466 | P35475 | |
| PNYGIVTEYASLGSL | 76 | Q9NYL2 | |
| IETYLLNVSPGGLTY | 421 | Q9NR34 | |
| VTRYQLDGLQPGTEY | 466 | Q02388 | |
| IVYFVAGVGVVYSPR | 36 | Q05BV3 | |
| GGQISVVISKGIPYY | 251 | Q96PD2 | |
| DVGLGKGRYYSVNVP | 216 | Q9BY41 | |
| GGYVLYPQIGDRLDL | 46 | Q15768 | |
| YGGIRSDPVTLNVLY | 316 | Q00888 | |
| GQIIIYGPAYSGRET | 86 | Q9UQ72 | |
| TVVYGVTRYGGRLQI | 996 | O00411 | |
| VSEKQYTIYIAPGGG | 356 | Q06587 | |
| GEIIIYGPAYSGRET | 86 | P11464 | |
| YGGIRSDPVTLNVLY | 316 | P11464 | |
| GQIIIYGPAYSGRET | 86 | Q16557 | |
| EIQDRYGGIRSYPVT | 311 | Q16557 | |
| SGTYGVYEIGGLVPV | 376 | Q6J4K2 | |
| IAYPLVEGVTEGYNG | 71 | Q9P2E2 | |
| GVVVYSGGRYDLLPS | 451 | Q9NSD7 | |
| SGLFLRITGGEPYLY | 441 | Q9GZV3 | |
| DYRSLVIGLQYGGLP | 176 | O14994 | |
| YGLEPFTTYRIGVVA | 4031 | O75445 | |
| ISYSVAYALGPIVAG | 426 | Q16572 | |
| YVYGVVPISLCRGGG | 431 | Q6ZMZ0 | |
| LSYGYQGRSFEPVGT | 381 | Q8NBJ9 | |
| TTRTQNVTVGGYYPG | 51 | Q5JRV8 | |
| NVTVGGYYPGVILGF | 56 | Q5JRV8 | |
| ENVTVGGYYPGIILG | 51 | Q8WV15 | |
| AGGEPYRLLTGVEYV | 11 | O60934 | |
| GQIIYGPAYSGRETV | 86 | Q00889 | |
| GQIIIYGPAYSGRET | 86 | Q9UQ74 | |
| EIRDQYGGIRSYPVT | 311 | Q9UQ74 | |
| GKIIIYGPAYSGRET | 86 | Q00887 | |
| VYSLPRVGVGTSYGL | 2251 | Q8NFP9 | |
| YLLGSDYTEGIPTVG | 856 | P28715 | |
| IVVRGYAIGYGIGSP | 766 | Q92859 | |
| IRIGNITPADAGTYY | 106 | P78324 | |
| LSVYSAGRIPGGYVT | 216 | Q9P202 | |
| AGRIPGGYVTNHIYT | 221 | Q9P202 | |
| LTAVYTSPGNEGVIY | 426 | Q8IZU2 | |
| PQKVGAYRSYIQGGR | 1446 | O95785 | |
| IGQTVRISQGPYKGY | 706 | O00267 | |
| TRLPSDYIYGIGEQV | 231 | P14410 | |
| GQIIKYGPAYSGRET | 86 | Q13046 | |
| YGGIRSDPVTLNVLY | 316 | Q13046 | |
| SDGNTITIYYPNGGR | 641 | O00444 | |
| NGRLVYLVENPGGYV | 206 | P02786 | |
| GTPEAYEGLGIRYLG | 101 | Q9BV47 | |
| YTPTGYGTLVQEGGA | 156 | Q9BYC2 | |
| YGTLVQEGGAPIRYT | 161 | Q9BYC2 | |
| RCVPGVGIYFGTLYS | 96 | Q96DW6 | |
| VNTIGYYVVGLPIGI | 411 | Q96FL8 | |
| YIPEGEILVITYGRS | 191 | Q9Y3F4 | |
| VGGNAPLYYEVLTAA | 96 | Q6Q759 | |
| LGPEVTTQYGGQYRT | 31 | P13798 | |
| LYRPGSVAYVSRSGG | 651 | P53396 | |
| VYEGVAIGGDRYPGS | 681 | P53396 | |
| IIGYLPFEVLGTSGY | 296 | O15516 | |
| GGEGYVPTSYLRVTL | 586 | Q15642 | |
| TYRIVPGGYAVVGAA | 491 | P51788 | |
| DYRGYRVTAQSIIPG | 476 | O75153 | |
| QDSGYLIVYVTGRPD | 1056 | O00562 | |
| VSYVPVNGRLYELDG | 166 | Q9Y5K5 | |
| GIGFVITLTGVPAYY | 451 | Q9UPY5 | |
| RGTIAVGLVPQYYSL | 91 | Q8NCJ5 | |
| PRELASAGLYYTGIG | 181 | P98170 | |
| ALSVGIYQVGSSPLY | 876 | P10745 | |
| SLDVGGPLRYAVYGF | 66 | Q9NR77 | |
| PSIGIYGLDFYVVLG | 121 | P62913 | |
| VQVLGVPSEAYRYGL | 71 | Q92911 | |
| SIAYSLLAGQEPVYG | 126 | P50443 | |
| VRTFVGYGYNIEPSD | 1041 | Q15413 | |
| SLRTGVSGVFPGNYV | 506 | Q8TEJ3 | |
| GVYTGPEFYTGLEIQ | 171 | Q5VZP5 | |
| FPGNLYRGEGIVYGT | 46 | Q9NSY2 | |
| AATPYTVSIYGVIQG | 1136 | P24821 | |
| TVSIYGVIQGYRTPV | 1141 | P24821 | |
| GLEAATPYRVSIYGV | 1406 | P24821 | |
| YGTYVTILPELGGYI | 311 | Q8IZH2 | |
| YNPGYVLASRLGVSG | 911 | Q8IZH2 | |
| GVIPQGEYEGDSLYR | 906 | Q9HBJ7 | |
| TYSPGGYIAGIQRGI | 1886 | Q6N022 | |
| ITGTGRQGIFPASYV | 496 | O60504 | |
| YSGPGYGILSLVVSE | 806 | O15040 | |
| LAFVYGSGVYRQAGP | 26 | Q96BW9 | |
| ADIYQTPRYLVIGTG | 21 | P0DTU4 | |
| TITGNIYIYNGPVLG | 356 | P36941 | |
| TVGQLAEGGYPLRFS | 16 | Q9Y2H8 | |
| TGYKIPRGGLFEYVT | 181 | P18405 | |
| ADIYQTPRYLVIGTG | 21 | A0A075B6N4 | |
| EVAYGQVLGVIGYSL | 161 | Q9BSR8 | |
| GQIIIYGPAYSGRET | 86 | P11465 | |
| RGPGLYYVDSEGNRI | 166 | P28074 | |
| GLEYTGIYRVPGNNA | 1176 | Q5T5U3 | |
| DIFYSRYGGGPRLTV | 536 | Q86UV5 | |
| SGYSGYKQVQVPRGR | 656 | A4D1P6 | |
| GQINIYGPAYTGRET | 86 | Q15238 | |
| YESPAGYGLIGLQVA | 311 | Q8NBT3 | |
| TGPGVRVHYGLYNQS | 441 | Q8IU80 | |
| GCGRPNYFGVYTRIT | 786 | Q8IU80 | |
| RLVYRYGGEPVGSFV | 591 | P35573 | |
| VYRDLQPVGSGAYGA | 26 | P53778 | |
| AYDGGQPILGYILER | 796 | Q14896 |